5 amino 1mq peptide dosage protocol 5 amino 1mq dosage protocol Dosage and Administration Guide 5-Amino-1MQ 5MG Research Peptide |

1 Mecobalamin 50 mg or placebo was administered intramuscularly twice weekly for 16 weeks to 130 ALS patients who had suffered from ALS for less than one year, were classified as definite, probable, or probable-laboratory supported according to the Updated Awaji Criteria, had an ALS severity rating of grade 1 or 2, had a decrease of 1 or 2 points in the total score on the Revised ALS Functional Rating Scale-Revised (ALSFRS-R) 12 weeks prior to administration, and had a forced vital capacity (%FVC) of more than 60%

inability to concentrate well

Additionally, individuals with certain conditions, like Lebers disease (an optic nerve condition), should avoid B12 injections

Which Is Better: Injections or Oral Supplements